ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.70
+0.10 (0.49%)
Apr 29, 2026, 1:30 PM CST

ScinoPharm Taiwan Company Description

ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas.

It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services.

The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.

ScinoPharm Taiwan, Ltd.
Country Taiwan
Founded 1997
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 540
CEO Li-An Lu

Contact Details

Address:
No. 1, Nan-Ke 8th Road
Tainan City, 741014
Taiwan
Phone 886 6 505 2888
Website scinopharm.com

Stock Details

Ticker Symbol 1789
Exchange Taiwan Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0001789006
SIC Code 2834

Key Executives

Name Position
Li-An Lu President and Chief Executive Officer
Zhi-Xian Luo Chairman and General Chief Strategy Officer
Chih-Hui Lin Senior Director of Accounting, Finance and Corporate Governance Officer
Ling-Hsiao Lien Vice-President of Marketing, Sales and Operations
Dr. Li-Chiao Chang Chemistry, Ph.D. Vice President of Research & Development Division and Chief Scientific Officer
Jason Chen Director of Human Resources and Admin
Shun Yang Lin Director of Corporate Development
Yao-Hui Wang Senior Manager-Division of Accounting